background
human
bocaviru
hbov
parvoviru
recent
detect
patient
respiratori
ill
object
develop
sensit
specif
quantit
realtim
pcr
assay
base
taqman
method
hbov
detect
quantif
respiratori
specimen
studi
design
three
individu
realtim
pcr
assay
design
amplifi
hbov
gene
clinic
evalu
nasal
aspir
obtain
patient
acut
respiratori
tract
infect
decemb
may
test
result
assay
broad
dynam
rang
copi
plasmid
dna
high
interand
intraassay
reproduc
detect
limit
assay
genom
copi
per
reaction
crossreact
major
respiratori
virus
bacteria
detect
clinic
evalu
reveal
patient
diagnos
upper
respiratori
tract
infect
pneumonia
bronchiti
pharyng
sinus
hbov
detect
three
assay
viral
load
rang
copiesml
specimen
conclus
three
assay
hbov
diagnosi
quantif
highli
sensit
specif
realtim
tool
reliabl
epidemiolog
pathogenet
studi
hbov
infect
use
random
amplif
method
human
bocaviru
hbov
identifi
pool
respiratori
specimen
children
lower
respiratori
tract
infect
alland
et
al
hbov
classifi
famili
parvovirida
subfamili
parvovirina
genu
bocaviru
recent
initi
detect
hbov
respiratori
secret
sever
preval
studi
children
respiratori
tract
infect
report
worldwid
preval
rang
arnold
et
al
bastien
et
al
choi
et
al
kesebir
et
al
et
al
sloot
et
al
weissbrich
et
al
present
applic
identif
method
hbov
convent
realtim
pcr
hbov
cultur
serolog
method
yet
establish
gener
realtim
pcr
advantag
amplif
analysi
complet
close
system
less
prone
contamin
sensit
specif
convent
pcr
quantifi
gene
copi
number
larg
number
sampl
process
singl
step
without
labori
postanalysi
espi
et
al
previou
studi
introduc
realtim
pcr
method
target
gene
high
sensit
specif
lu
et
al
articl
present
highli
sensit
specif
taqmanbas
realtim
pcr
assay
rapid
detect
quantit
hbov
clinic
specimen
full
sequenc
hbov
retriev
strain
genbank
access
design
primer
probe
hbov
gene
analyz
target
site
applic
taqman
realtim
pcr
requir
use
primer
express
softwar
version
appli
biosystem
foster
citi
ca
taqman
mgb
probe
label
fam
end
black
hole
quencher
end
tabl
kbp
hbov
full
genom
amplifi
forward
primer
revers
primer
pcrposit
specimen
product
clone
plasmid
vector
invitrogen
carlsbad
ca
verifi
sequenc
plasmid
purifi
qiamp
mini
prep
kit
qiagen
hilden
germani
quantifi
use
uv
spectroscopi
dna
copiesl
standard
curv
gener
serial
dilut
plasmid
prepar
mm
trisedta
buffer
ph
store
c
realtim
pcr
assay
perform
reaction
mixtur
contain
l
extract
dna
standard
plasmid
l
taqman
univers
pcr
master
mix
contain
rox
passiv
refer
dye
appli
biosystem
nm
forward
revers
primer
nm
probe
amplif
detect
perform
abi
prism
sequenc
detect
system
appli
biosystem
follow
condit
uracilnglycosylas
ung
activ
c
min
follow
pcr
activ
c
min
cycl
amplif
c
min
c
analysi
assay
perform
use
sequenc
detector
softwar
version
appli
biosystem
sensit
assay
determin
use
copi
plasmid
per
reaction
specif
test
genom
major
caus
agent
respiratori
ill
includ
dnarna
virus
bacteria
use
tabl
intraand
interassay
perform
triplic
three
differ
day
evalu
reproduc
compar
sensit
realtim
pcr
convent
pcr
perform
amplifi
bp
fragment
gene
bp
use
follow
primer
set
pcr
assay
perform
reaction
volum
contain
l
dna
extract
l
pcr
buffer
l
dntp
mix
final
concentr
dntp
l
sp
taq
cosmo
gentec
seoul
korea
l
primer
pm
nucleasefre
water
l
pcr
reaction
carri
c
min
cycl
amplif
c
c
c
final
extens
step
c
min
pcr
product
run
agaros
gel
stain
sybr
safe
dna
gel
stain
dye
invitrogen
visual
uv
light
decemb
may
nasal
aspir
collect
patient
acut
respiratori
infect
visit
local
clinic
median
age
month
specimen
collect
studi
carri
part
acut
respiratori
tract
infect
surveil
korea
center
diseas
control
kcdc
inform
consent
obtain
children
parent
patient
age
distribut
patient
month
year
year
year
year
male
femal
ratio
diagnos
patient
upper
respiratori
infect
pharyng
bronchiti
croup
pneumonia
otiti
media
sinus
specimen
collect
total
nucleic
acid
extract
l
aliquot
specimen
within
h
use
autom
magna
pure
lc
total
nucleic
acid
extract
kit
roch
diagnost
mannheim
germani
specimen
test
common
respiratori
virus
influenza
virus
ab
rsv
piv
coronavirus
rhinoviru
adenovirus
use
modifi
version
previous
describ
multiplex
pcr
revers
transcript
pcr
na
et
al
paul
et
al
rest
specimen
kept
c
quantif
hbov
full
genom
size
hbov
plasmid
dna
use
gener
standard
curv
serial
dilut
span
copi
plasmid
use
per
reaction
mixtur
reaction
perform
triplic
standard
curv
gener
assay
show
amplif
effici
greater
linear
regress
better
three
assay
dynam
rang
assay
analyz
mean
c
valu
log
unit
correspond
c
valu
detect
limit
assay
determin
use
replic
primerprob
set
copi
plasmid
dna
ten
copi
result
detect
rate
five
copi
analyt
detect
limit
decreas
lowest
level
one
copi
templat
gene
detect
higher
target
gene
crossreact
dna
virus
human
parvoviru
adenoviru
herp
simplex
viru
human
herp
viru
varicellazost
viru
respiratori
pathogen
bacteria
includ
haemophilu
influenza
legionella
pneumophila
streptococcu
pneumonia
mycoplasma
pneumonia
chlamydia
pneumonia
assess
appli
three
assay
ng
dna
speci
addit
cdna
respiratori
rna
virus
influenza
viru
ab
parainfluenza
virus
rsv
coronaviru
rhinoviru
enteroviru
evalu
exclud
possibl
amplif
revers
transcript
nonspecif
amplif
detect
sampl
three
assay
intraand
interassay
reproduc
assess
use
serial
dilut
standard
hbov
plasmid
dna
rang
copi
triplic
three
differ
day
intraassay
variat
rang
interassay
variat
show
high
assay
reproduc
precis
tabl
assess
sensit
realtim
pcr
compar
convent
pcr
serial
dilut
standard
hbov
plasmid
dna
rang
copi
templat
use
detect
limit
gelbas
convent
pcr
assay
amplifi
gene
copi
hbov
plasmid
dna
fig
hand
shown
detect
limit
three
realtim
pcr
assay
obtain
plasmid
dna
sampl
low
copi
sensit
realtim
pcr
equival
increas
two
log
unit
convent
pcr
assay
clinic
evalu
three
newli
develop
realtim
pcr
assay
use
detect
hbov
nasal
aspir
collect
patient
acut
respiratori
tract
infect
among
specimen
posit
three
target
three
posit
two
target
three
posit
singl
target
two
one
posit
criteria
defin
three
primerprob
set
posit
copi
target
rtpcr
result
common
respiratori
virus
indic
specimen
posit
rhinoviru
influenza
viru
rsv
adenoviru
influenza
viru
b
parainfluenza
viru
coronaviru
among
patient
gave
hbovposit
specimen
two
patient
coinfect
rsv
one
patient
rhinoviru
interestingli
one
sam
ple
posit
convent
pcr
contain
mean
copiesml
hbov
realtim
pcr
assay
consid
posit
assay
clinic
specimen
detect
limit
around
genom
copi
clinic
characterist
posit
patient
eight
infant
two
adult
diagnos
upper
respiratori
infect
bronchiti
pneumonia
pharyng
sinus
describ
tabl
quantit
realtim
pcr
assay
provid
sensit
specif
diagnost
tool
target
three
put
orf
allow
quantif
hbov
clinic
specimen
assay
perform
wide
dynam
rang
low
intraand
interassay
variat
show
crossreact
respiratori
virus
bacteria
sensit
three
assay
significantli
higher
convent
pcr
assay
defin
posit
criteria
minim
fals
posit
test
clinic
specimen
triplic
defin
posit
result
three
independ
assay
posit
practic
laboratori
applic
howev
assay
target
gene
seem
effici
reliabl
gene
highli
conserv
previou
report
care
prevent
possibl
contamin
pcr
prepar
pcr
premix
control
plasmid
dna
clinic
sampl
process
perform
separ
room
lu
et
al
moreov
realtim
pcr
perform
close
system
ung
ad
pcr
master
mix
anoth
level
control
amplicon
contamin
espi
et
al
howev
could
exclud
factor
might
lead
fals
posit
result
crosscontamin
specimen
handl
nucleic
acid
extract
mention
applic
assay
clinic
diagnosi
estim
use
respiratori
specimen
patient
acut
respiratori
tract
infect
broad
rang
hbov
genom
copi
number
detect
interestingli
one
specimen
lower
viral
load
among
posit
miss
convent
pcr
reflect
sensit
realtim
assay
moreov
best
knowledg
first
report
identifi
hbov
infect
adult
korea
previous
lu
et
al
report
hbov
pcrposit
patient
pneumonia
rel
low
viral
load
although
clinic
data
requir
interpret
correl
pathogenesi
viral
load
realtim
assay
describ
studi
would
provid
use
tool
analysi
clinic
molecular
epidemiolog
investig
hbov
infect
